Company: IMNN
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001641172-25-009572
Chunk: 97

Company: Imunon, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 8
Chunk 97
---
     40,600  
     40,600 
  
    Total 
    $3,543,407  
    $3,033,747 

    10

Note 7. Stockholders’ Equity

On May 15, 2024, the Company filed with the SEC a
shelf registration statement on Form S-3 (the “2024 Registration Statement”) for the offer and sale of up to $75 million of
its securities. The 2024 Registration Statement was declared effective on May 22, 2024. The 2024 Registration Statement is intended to
provide the Company with flexibility to raise capital in the future for general corporate purposes. However, the Company’s ability
to offer and sell its securities in a primary offering on the 2024 Registration Statement is limited by General Instruction I.B.6 of Form
S-3 (the “Baby Shelf Limitation”), which limits the amount that the Company can offer to up to one-third of its public float
during any trailing 12-month period. The Company would no longer be subject to the Baby Shelf Limitation if its public float exceeds $75
million.

At the Market Offering Agreement

On May 15, 2024, the Company amended the At the Market
Offering Agreement, dated as of May 25, 2022 (the “ATM Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”)
as sales agent. Pursuant to the terms of the amended ATM Agreement, the Company may offer and sell, from time to time, through Wainwright,
shares of the Company’s common stock having an aggregate offering price of up to $5,500,000. The Company intends to use the net
proceeds from any offering under the amended ATM Agreement for general corporate purposes, including research and development activities,
capital expenditures and working capital.

On July 30, 2024, the Company notified Wainwright
that it was suspending its use of and terminating the “at the market offering” sales agreement prospectus (the “ATM
Prospectus”), related to the potential issuance from time to time of the Company’s common stock pursuant to the ATM Agreement,
by and between the Company and Wainwright. Notwithstanding the termination of the ATM Prospectus, the ATM Agreement remains in full force
and effect.

On September 3, 2024, the Company filed a new prospectus
supplement to the 2024